T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
XYZ
Block Inc
XYZ
|
+$2.39B |
| 2 |
Carvana
CVNA
|
+$1.82B |
| 3 |
Microsoft
MSFT
|
+$1.5B |
| 4 |
Walt Disney
DIS
|
+$1.25B |
| 5 |
Spotify
SPOT
|
+$1.05B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$2.65B |
| 2 |
Intuit
INTU
|
+$2.08B |
| 3 |
Match Group
MTCH
|
+$1.87B |
| 4 |
Salesforce
CRM
|
+$1.76B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.61B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.08% |
| 2 | Healthcare | 16.24% |
| 3 | Consumer Discretionary | 15.33% |
| 4 | Communication Services | 13.82% |
| 5 | Financials | 12.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
Alnylam Pharmaceuticals
ALNY
$30.2B
| $1.11B | 0.1% |
5,874,235
+349,557
| +6% | +$65.6M |
|
202
Union Pacific
UNP
$177B
| $1.11B | 0.1% |
5,649,252
+1,240,659
| +28% | +$268M |
|
203
MGM Resorts International
MGM
$11.2B
| $1.11B | 0.1% |
25,632,997
+6,835,459
| +36% | +$279M |
|
204
Paycom
PAYC
$9.54B
| $1.11B | 0.1% |
2,230,260
-15,333
| -0.7% | -$6.83M |
|
205
Molina Healthcare
MOH
$10.9B
| $1.1B | 0.1% |
4,067,777
-16,516
| -0.4% | -$4.36M |
|
206
News Corp Class A
NWSA
$15.7B
| $1.1B | 0.1% |
46,720,552
+545,501
| +1% | +$12.9M |
|
207
CF Industries
CF
$17.8B
| $1.1B | 0.1% |
19,687,635
-756,218
| -4% | -$36.3M |
|
208
ConocoPhillips
COP
$150B
| $1.1B | 0.1% |
16,188,040
-1,873,186
| -10% | -$108M |
|
209
Tradeweb Markets
TW
$22B
| $1.09B | 0.1% |
13,509,533
-309,463
| -2% | -$26.7M |
|
210
Workday
WDAY
$44.2B
| $1.07B | 0.1% |
4,280,846
-2,589,874
| -38% | -$641M |
|
211
Clarivate
CLVT
$1.22B
| $1.06B | 0.1% |
48,569,566
-20,680,975
| -30% | -$503M |
|
212
Loews
L
$23.1B
| $1.05B | 0.1% |
19,536,876
-1,098,827
| -5% | -$59.7M |
|
213
Procter & Gamble
PG
$338B
| $1.05B | 0.1% |
7,488,893
-118,426
| -2% | -$16.8M |
|
214
Copart
CPRT
$27.2B
| $1.03B | 0.1% |
29,808,752
+5,642,816
| +23% | +$202M |
|
215
Vertex Pharmaceuticals
VRTX
$133B
| $1.03B | 0.1% |
5,698,247
-7,400,245
| -56% | -$1.44B |
|
216
Ultragenyx Pharmaceutical
RARE
$2.61B
| $1.03B | 0.1% |
11,459,046
+459,832
| +4% | +$41.6M |
|
217
State Street
STT
$52.3B
| $1.02B | 0.1% |
12,067,520
+3,075,002
| +34% | +$267M |
|
218
Pinduoduo
PDD
$123B
| $1.02B | 0.1% |
11,242,760
+7,308,062
| +186% | +$711M |
|
219
CMS Energy
CMS
$22.1B
| $1.02B | 0.1% |
17,026,924
+9,207,824
| +118% | +$575M |
|
220
Mondelez International
MDLZ
$80.6B
| $1.01B | 0.1% |
17,441,163
+1,327,552
| +8% | +$82.6M |
|
221
International Flavors & Fragrances
IFF
$21.6B
| $1.01B | 0.1% |
7,559,221
-208,610
| -3% | -$30.6M |
|
222
Cboe Global Markets
CBOE
$30.5B
| $996M | 0.09% |
8,045,010
-1,480,899
| -16% | -$181M |
|
223
NiSource
NI
$20.2B
| $994M | 0.09% |
41,035,840
-6,105,100
| -13% | -$152M |
|
224
Dominion Energy
D
$60B
| $993M | 0.09% |
13,602,367
+5,165,368
| +61% | +$394M |
|
225
Alcon
ALC
$35.7B
| $987M | 0.09% |
12,194,117
+745,513
| +7% | +$57.4M |
|
Similar funds
T. Rowe Price Associates's Q3 2021 Portfolio in Review
As of Q3 2021, T. Rowe Price Associates held 3,048 positions worth $1.06T, down 1.6% from $1.08T the previous quarter. Its ten largest holdings account for 26% of the portfolio.
T. Rowe Price Associates's Q3 2021 filing shows 131 new, 1,029 increased, 1,524 reduced and 112 closed positions. Its largest new stake was Warby Parker: 17,643,113 shares worth $936M. The largest sale was Visa, an estimated $2.65B.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 25% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q3 2021 buy was Warby Parker: 17,643,113 shares worth $936M.
- T. Rowe Price Associates added most to Block Inc in Q3 2021, an estimated $2.39B increase.
- T. Rowe Price Associates's biggest Q3 2021 reduction was Visa, cutting an estimated $2.65B.
- T. Rowe Price Associates fully exited Maxim Integrated Products in Q3 2021, selling an estimated $394M.
- T. Rowe Price Associates's ten largest holdings make up 26% of its $1.06T portfolio in Q3 2021.
- T. Rowe Price Associates opened 131 new positions and closed 112 in Q3 2021.
- T. Rowe Price Associates's portfolio value fell 1.6% quarter-over-quarter to $1.06T.
Based on T. Rowe Price Associates's 13F filing for Q3 2021, filed 15 Nov 2021.